Significant association between <i>HLA‐B*35:01</i> and onset of drug‐induced liver injury caused by Kampo medicines in Japanese patients
Ryosuke Nakamura(National Institute of Advanced Industrial Science and Technology), Hajime Takikawa(Teikyo University), Yoshiro Saito(National Institute of Health Sciences), Yoichi Hiasa(Ehime University Hospital), Hiromasa Ohira(Fukushima Medical University), Yoichi Mashimo(Chiba University), Noriaki Arakawa(National Institute of Health Sciences), Akihiro Sekine, Yoïchi Tanaka(Mercy Willard Hospital), Nahoko Uchiyama(National Institute of Health Sciences), Ken Sato(Gunma University), Masaaki Watanabe(Kitasato University), Mitsuhiko Aiso(Teikyo University), Keiko Maekawa(National Institute of Health Sciences), Masahiro Tohkin(National Institute of Health Sciences), Tatehiro Kagawa(Tokai University), Yoshiyuki Takei(The Japanese Society of Gastroenterological Surgery), Eri Tsukagoshi(National Institute of Health Sciences), Minoru Ayada(Hamamatsu University Hospital), Keiji Tsuji(Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital)
Cited by 13
Related Papers
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
HLA-B Locus in Japanese Patients with Anti-Epileptics and Allopurinol-Related Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
|Pharmacogenomics|2008|408
Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin
|American Journal of Roentgenology|2007|345
The global distribution of pure anorthosite on the Moon
|Nature|2009|324
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272